Octagon Capital Advisors LP - 31 Dec 2025 SCHEDULE 13G/A Report for Corbus Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value (CRBP)

Filing Manager
Octagon Capital Advisors LP
Reporting Manager
Octagon Capital Advisors LP
Security
Corbus Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value
Symbol
CRBP
Shares outstanding
17,685,185 shares
Disclosed Ownership
955,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2026, 13:14:49 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Octagon Capital Advisors LP disclosed 5.4% ownership in Corbus Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value (CRBP) on 31 Dec 2025."

Quick Takeaways

  • Octagon Capital Advisors LP filed SCHEDULE 13G/A for Corbus Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value (CRBP).
  • Disclosed ownership: 5.4%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2026, 13:14.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Octagon Capital Advisors LP 5.4% 955,000 0 955,000 /s/ Ting Jia Managing Member
Octagon Investments Master Fund LP 5.4% 955,000 0 955,000 /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia 5.4% 955,000 0 955,000 /s/ Ting Jia Ting Jia

Sponsored